• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

LRRK2-IN-1

CAS No. 1234480-84-2

LRRK2-IN-1 ( LRRK 2-IN-1 )

产品货号. M10936 CAS No. 1234480-84-2

一种有效的 LRRK2 抑制剂,对野生型/G2019S 突变体 LRRK2 的 IC50 分别为 13 nM/6 nM(测定中为 0.1 mM ATP)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥486 有现货
10MG ¥697 有现货
25MG ¥1434 有现货
50MG ¥2600 有现货
100MG ¥4560 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    LRRK2-IN-1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种有效的 LRRK2 抑制剂,对野生型/G2019S 突变体 LRRK2 的 IC50 分别为 13 nM/6 nM(测定中为 0.1 mM ATP)。
  • 产品描述
    A potent LRRK2 inhibitor with IC50s of 13 nM/6 nM for wild-type/G2019S mutant LRRK2 repectively (0.1 mM ATP in the assay); shows modest activity against LRRK2 A2016T (IC50=2.45 uM) and LRRK2 A2016T+G2019S mutant (IC50=3.08 uM); also inhibits DCLK1 (IC50=2.61 nM) and 2 (IC50=45 nM); induces dephosphorylation of Ser910 and Ser935 of LRRK2 and alters the cytoplasmic localisation of LRRK2.
  • 体外实验
    Wild-type and G2019S transduction results in 2.5 fold higher TR-FRET signal which can be inhibited by LRRK2-IN-1 in a dose-dependent manner with IC50 values of 0.08 μM and 0.03 μM, respectively. LRRK2-IN-1 possessed an IC50 of 45 nM for inhibition of DCLK2 and exhibits an IC50 of greater than 1 μM when evaluated in biochemical assays for AURKB, CHEK2, MKNK2, MYLK, NUAK1, and PLK1. LRRK2-IN-1 is confirmed to inhibit MAPK7 with an EC50 of 160 nM. LRRK2-IN-1 induces a dose dependent inhibition of Ser910 and Ser935 phosphorylation accompanied by loss of 14-3-3 binding to both wild type LRRK2 and LRRK2[G2019S] stably transfected into HEK293 cells. LRRK2-IN-1 is moderately cytotoxic with IC50 of 49.3 μM in HepG2 cells. LRRK2-IN-1 exhibits genotoxicity in the presence and absence of S9 at 15.6 and 3.9 μM, respectively. LRRK2-IN-1 inhibits proliferation, migration, and induces cell death with hallmarks of apoptosis of HCT116 and AsPC-1 cells.
  • 体内实验
    LRRK2-IN-1 (100 mg/kg, i.p.) induces dephosphorylation of LRRK2 in the kidney of the mice. Peritumoral injection of LRRK2-IN-1 (100 mg/kg) results in a significant decrease in tumor volume and weight of AsPC-1 tumor xenografts.
  • 同义词
    LRRK 2-IN-1
  • 通路
    Autophagy
  • 靶点
    LRRK2
  • 受体
    DCLK1|DCLK2|LRRK2(A2016T)|LRRK2(G2019S)|LRRK2(WT)
  • 研究领域
    Neurological Disease
  • 适应症
    ——

化学信息

  • CAS Number
    1234480-84-2
  • 分子量
    570.6852
  • 分子式
    C31H38N8O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C1N(C)C2=CN=C(NC3=CC=C(C(N4CCC(N5CCN(C)CC5)CC4)=O)C=C3OC)N=C2N(C)C6=CC=CC=C16
  • 化学全称
    6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one, 5,11-dihydro-2-[[2-methoxy-4-[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]phenyl]amino]-5,11-dimethyl-

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Deng X, et al. Nat Chem Biol. 2011 Apr;7(4):203-5. 2. Weygant N, et al. Mol Cancer. 2014 May 6;13:103. 3. Luerman GC, et al. J Neurochem. 2014 Feb;128(4):561-76.
产品手册
关联产品
  • MLi-2

    一种有效的、选择性的、口服的脑渗透性 LRRK2 抑制剂,激酶 IC50 为 0.76 nM,细胞 IC50 为 1.4 nM(LRRK2 pSer935 LRRK2 去磷酸化)。

  • GNE-7915

    一种高效、选择性、脑渗透性 LRRK2 抑制剂,IC50 为 1.9 nM。

  • GNE-9605

    GNE-9605 是一种高效、选择性、脑渗透性 LRRK2 抑制剂,Ki 为 2 nM,pLRRK2 IC50 为 19 nM。